Health IT

New preclinical data shows RTY-406 could be a first-in-class therapy for PSC, a progressive liver disease with no effective treatments.

Free skin cancer screenings in Ottawa highlight a national health crisis as wait times soar and experts demand urgent government action on specialist care.

Wellness brand Le-Vel is launching a telehealth service for prescription peptides, blurring the lines between direct sales and mainstream medicine.

A new partnership between TD2 Oncology and Panome Bio aims to merge clinical expertise with deep multi-omics data to accelerate personalized cancer therapies.

Vanda Pharmaceuticals' rare disease drug gets a key designation in Japan, unlocking major incentives and promising a new treatment for a severe skin disease.

Asset Workflows secures major funding to expand its data management solutions into the APAC region and the highly regulated healthcare sector.

A Canadian pilot's daring evacuation in the DRC highlights a new Ebola crisis, as a rare, untreatable strain spreads through the conflict-ridden region.

A landmark approval paves the way for a 200-bed cancer hospital in Nepal's most underserved province, promising hope and advanced care to millions.

Former Samsung smartphone chief Blake Gaiser joins Eyesafe, signaling a major push to embed vision wellness tech into every device you own.

Philadelphia Works adds top executives from Penn Medicine, the YMCA, and City Hall to its board, signaling a strategic push to tackle workforce gaps.

A major merger backed by US private equity creates a new powerhouse in Romania's complex care market, raising questions about access and physician roles.

John Theurer Cancer Center presents breakthroughs in CAR-T, ADCs, and health equity at ASCO, offering new hope for patients worldwide.

Prezent Vivo and Nested Knowledge partner to close the 'insight-to-action' gap, delivering AI-powered intelligence to pharma teams at unprecedented speed.

Venture firm JVP leverages its strategic focus on vertical AI and cybersecurity, cashing in on four major portfolio exits in a landmark first quarter.

Village Medical Arizona and others are now Bookmark Medical. Discover the strategy behind this national rebranding and its impact on patient care.

For 20 years, a Bahamian resort has quietly built a conservation powerhouse. Inside its mission to rescue turtles, grow coral, and redefine tourism.

Ionetix wins FDA approval for its generic prostate cancer imaging agent, a move set to boost access and shake up the competitive radiopharmaceutical market.

With new funding from Bregal Sagemount, LSPedia is set to advance its AI tools, moving beyond compliance to build a smarter, safer pharma supply chain.

Following its X3D acquisition, Catalyst MedTech unveils an expanded portfolio and a new strategy to tackle aging equipment and modernize nuclear medicine.

Triage Cancer and Bright Spot Network launch a free national program offering legal, financial, and emotional support to families facing a parent's illness.